Member Info for Newuncle

Dug,

Apology accepted.

Fwiw, example of recent bid for another company timeline for a company called Fire Angel (FA.)

LRB must be really close now (3 weeks so far since Tender Offer RNS) and looking at the above 4 weeks delivery so next week for new?

Date Source Headline

24th Nov 2023 7:00 am RNS Acceptance Level Announcement

2nd Nov 2023 6:10 pm RNS POSTING OF OFFER DOCUMENT

27th Oct 2023 7:00 am RNS Rule 2.7 Announcement

Roger don't forget the other big influencers out there.....the CFD and Spread Companies where people can leverage trades by many factors above what they have in real money.

Those 10% traders are pros, they trade for a living here , there and everywhere. Do it enough times and they can make a decent living from it but they need to be busy every day at it. I prefer buying the position I want and then seeing it develop. Each to their own in the end but we can't avoid them pesky traders, even more so these days.

Rabbit,

There are alot of traders who buy and sell on chart trends and Technical Analysis only, I know because I used to know a few.

Mostly they didn't even care about the name of the company or what it actually was doing now or could be doing in the future, they simply traded the ticker and any price movements either way, often daily. They will often pick shares like this one that have alot of interest but it could one of many they trade each day.

Actually agree with AHS there and very funny too.

Fwiw

Coalculus have four co-founders: Jack Bai, Doris Bai, Cheryl Lam and Shayne Tan. Jack Bai is the CEO of Wise MPay Pte Ltd — the parent company behind the Coalculus Platform and COAL.

What the management have shown us is that have delivered on what they promised ahead of schedule, fantastic achievement. UK Stock Market never seems to be able to value companies like this properly, its no wonder so many commentators keep saying the same in public now too and why more companies are leaving the London SE to either go private or to other exchanges.

Breq

Well said.

So has the volume of posts dried up (no bad thing really).

Guess fatigue has set in since the "market" called the short term 2p top here?

Insider,

Is Elon a mate of yours?

So no news is good news then re lack of RNS but confirmation of proposed constructions by the court?

Opinions are not Facts.

Selling a significant % of ones holding and then deciding to talk down the company is deramping, plain fact, not opinion.

Enough said.

You need advising, you really do and to downsize that ego of yours.

Your are really irritating

Dug,

Your superior attitude towards other posters really is grinding now, go buy another share.

I never said they wouldn't be looking at UK market, just that it would not be a higher priority that targeting the USA due to NICE/NHS requirements for approvals that can take a long time, unless of course they can get that fast tracked.

Dug,

UK market will come following accreditation of the UK Lab which the company have already stated is on track to be delivered very soon.

Dug,

Ok we get it.

For the rest of us, we can clearly see OBD's strategic direction below:

USA MARKETS BEING TARGETED BY OBD FOR PSE

At OBD, Dr Arrivo's role will be to implement effective marketing and sales strategies for the newly launched EpiSwitch® PSE prostate cancer detection test. His specific focus will be to grow sales in the US market, where he has considerable experience of launching products.

So your reasons for posting here are to what? Save others or get in cheaper?

Gimme,

OBD have so many potential regions to take the PSE test and CIRT test, they will be doing great business outside the UK, the NHS and NICE can be added as and when they are ready, OBD really don't need them to be successful in the short term ie in 2024, NHS/NICE can follow others lead.